EP Patent

EP0619814A1 — Oxadiazole derivatives having acetylcholinesterase-inhibitory and muscarinic agonist activity

Assigned to Fujisawa Pharmaceutical Co Ltd · Expires 1994-10-19 · 32y expired

What this patent protects

Heterocyclic compounds of the formula: R1-Q-Z-X-A-M, in which R1 represents lower alkyl, a heterocyclic group possibly having one or more suitable substituents, etc .; Q represents an oxadiazolediyl; Z represents a bond or vinyl; X represents a bond, a group of formula (I), (in w…

USPTO Abstract

Heterocyclic compounds of the formula: R1-Q-Z-X-A-M, in which R1 represents lower alkyl, a heterocyclic group possibly having one or more suitable substituents, etc .; Q represents an oxadiazolediyl; Z represents a bond or vinyl; X represents a bond, a group of formula (I), (in which R4 represents hydrogen or lower alkyl), a group of formula (II), (in which R8 represents hydroxy or protected hydroxy), etc .; A represents a bond, lower alkylene or lower alkymylene and M represents a heterocyclic group containing at least one nitrogen atom, which can have a substituent chosen from the group consisting of lower alkyl, an imino protecting group and (lower aralkyl) which can have a or more suitable substituents, and a pharmaceutically acceptable salt of these compounds used as a medicament.

Drugs covered by this patent

Patent Metadata

Patent number
EP0619814A1
Jurisdiction
EP
Classification
Expires
1994-10-19
Drug substance claim
No
Drug product claim
No
Assignee
Fujisawa Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.